Noble Partners

Latest statistics and disclosures from Noble Partners's latest quarterly 13F-HR filing:

Companies in the Noble Partners portfolio as of December 2011 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Us Natural Gas Fd Etf 20.51 -50% 450000 6.46
GOLAR LNG Limited Com 10.81 NEW 50000 30.66
Ariad Pharmaceuticals (ARIA) 7.34 +112% 85000 12.25
Jazz Pharmaceuticals (JAZZ) 6.81 +257% 25000 38.64
Pacific Ethanol Inc 6.73 NEW 900000 1.06
Allergan (AGN) 6.19 -9% 10000 87.70
Elan Corporation (ELN) 4.85 +25% 50000 13.74
Celgene Corporation (CELG) 4.77 NEW 10000 67.60
NPS Pharmaceuticals (NPSP) 3.95 NEW 85000 6.59
Akorn (AKRX) 3.92 -61% 50000 11.12
Johnson & Johnson (JNJ) 3.70 NEW 8000 65.62
Vertex Pharmaceuticals Incorporated (VRTX) 3.51 NEW 15000 33.20
Optimer Pharmaceuticals (OPTR) 3.46 NEW 40000 12.25
Amarin Corporation (AMRN) 3.17 +100% 60000 7.48
Insulet Corporation (PODD) 2.66 NEW 20000 18.85
Inhibitex (INHX) 2.31 NEW 30000 10.93
Perrigo Company (PRGO) 2.06 -62% 3000 97.33
Green Plains Renewable Energy (GPRE) 1.38 NEW 20000 9.75
Community Health Systems (CYH) 1.23 NEW 10000 17.50
Cardiome Pharma Corp 0.49 -72% 26100 2.64
ACADIA Pharmaceuticals (ACAD) 0.16 20000 1.10

Past 13F-HR SEC Filings by Noble Partners

View All Filings